Medical Advocates

HIV Infection/Disease
 
Hypertension


Hypertension
Portal Hypertension
Pulmonary Arterial Hypertension








 



 

HIV Vascular Main Page Main New/Newsworthy  Home Page      

Last Update: May 09, 2012
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader.

Hypertension   
       

         Journal Papers, Abstracts, and Comment

 
Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study.
Manner IW, Baekken M, Oektedalen O, Os I.
Blood Press
. 2012 May 8..
Abstract

Antihypertensive Drugs in Patients Treated with Antiretrovirals (May).
Peyriere H, Eiden C, Macia JC, Reynes J.
 
Ann Pharmacother
. 2012 May 1.
Abstract

Prevalence and risk factors associated with pulmonary hypertension in hiv-infected patients
on regular follow-up.[Spain]
Quezada M, Martin-Carbonero L, Soriano V,  et al

AIDS
. 2012 Apr 21..
Abstract

Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients.
Vecchiet J, Ucciferri C, Falasca K, et al

Antivir Ther
. 2011;16(5):639-45.
Abstract

Hypertension and Isolated Office Hypertension in HIV-Infected Patients Determined By
Ambulatory Blood Pressure Monitoring: Prevalence and Risk Factors.
Ji B, Fx Z,  Fj PP,  et al

J Acquir Immune Defic Syndr
. 2011 Jun 7.
Abstract

Hypertension, HIV infection, and highly active antiretrovíric therapy.
Bernardino de la Serna JI, Xavier Zamora F, Luisa Montes M, et al 
Enferm Infecc Microbiol Clin. 2009 Apr 29.
Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Antiretroviral medications associated with elevated blood pressure among patients
receiving highly active antiretroviral therapy.
Crane HM, Van Rompaey SE, Kitahata MM.
AIDS. 2006 Apr 24;20(7):1019-26.
Abstract
 

Hypertension in HIV-Infected Patients: Prevalence and Related Factors.
Jerico C, Knobel H, Montero M, et al 
Am J Hypertens. 2005 Nov;18(11):1396-1401.
Abstract
 
Association between highly active antiretroviral therapy and hypertension in a large cohort of men
followed from 1984 to 2003.
Seaberg EC, Munoz A, Lu M, et al 
AIDS.
2005 Jun 10;19(9):953-960.
Abstract
 
Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity.
Jung O, Bickel M, Ditting T,et al
 
Nephrol Dial Transplant.
2004 Jul 6
Abstract

Hypertension among HIV patients: prevalence and relationships to insulin resistance and
metabolic syndrome.
Gazzaruso C, Bruno R, Garzaniti A, et al

J Hypertens.
2003 Jul;21(7):1377-1382.
Abstract

 

          Conference Reports, Abstracts, and Posters

 
BMI and long-term NRTI treatment are significantly associated with hypertension
10 years after PI-ART start

G Bratt, S Liljeqvist, C Ek, et al 
(8th Int Congress on Drug Therapy in HIV Infection)
Abstract
 
A case control study of the prevalence of hypertension in an HIV-infected population compared
on a healthy age, sex and race matched control group
Crook T., Ahuja D., Modesir C., Zurlo J.
(XVI International AIDS Conference)
Abstract
 
Quality of care for HIV patients with comorbid hypertension
Goulet J.L., Fultz S.L., Justice A.C.
(XVI International AIDS Conference)
Abstract
 
A double burden? HIV and hypertension in rural South Africa
Bärnighausen T., Welz T., Hosegood V
(XVI International AIDS Conference)
Abstract
 
POSTER
Predictors of Successful Blood Pressure Management in HIV-infected Patients at Moderate to
High 10-year Risk of Coronary Heart Disease: The Swiss HIV Cohort Study
H Bucher, T Glass, R Weber, et al

(13 CROI)

PDF Poster     Abstract
 
POSTER
The Effect of HAART Initiation on Blood Pressure
E Seaberg , S Riddler, J Margolick, et al

(12 CROI)

PDF Poster     Abstract

 
The Association between Increasing Blood Pressure and Use of NNRTI and
Lopinavir/Ritonavir
H Crane, S Van Rompaey, M Kitahata

(12 CROI)
Abstract
 

Portal Hypertension
       

         Journal Papers, Abstracts, and Commentaries

 
Non-cirrhotic portal hypertension in HIV mono-infected patients.
Jackson BD, Doyle JS, Hoy JF, et al
J Gastroenterol Hepatol. 2012 Apr 13..
Abstract

Noncirrhotic portal hypertension in HIV infection.
Vispo E, Morello J, Rodriguez-Novoa S, Soriano V.

Curr Opin Infect Dis
. 2010 Dec 13
Abstract

Noncirrhotic Portal Hypertension in HIV-Infected Patients: A Case Control Evaluation and
Review of the Literature.
Cesari M, Schiavini M, Marchetti G, et al

AIDS Patient Care STDS
. 2010 Oct 23
Abstract

Idiopathic Portal Hypertension in Patients With HIV Infection Treated With Highly Active
Antiretroviral Therapy.

Chang PE, Miquel R, Blanco JL, et al
Am J Gastroenterol. 2009 May 26.

Abstract


Pulmonary Arterial Hypertension
       

         Journal Papers, Abstracts, and Comment

 
HIV-related pulmonary arterial hypertension
Savale L, Lador F, Jais X, et al
Rev Mal Respir. 2012 Apr;29(4):491-500.
Abstract

HIV infection and pulmonary arterial hypertension.
Cicalini S, Chinello P, Petrosillo N.
Expert Rev Respir Med. 2011 Apr;5(2):257-266
Abstract

Pulmonary hypertension associated with HIV infection: pulmonary vascular disease:
the global perspective.
Almodovar S, Cicalini S, Petrosillo N, Flores SC.

Chest
. 2010 Jun;137(6 Suppl):6S-12S.
Abstract

HIV and pulmonary arterial hypertension: a systematic review.
Janda S, Quon BS, Swiston J.

HIV Med
. 2010 Apr 7.
Abstract

HIV-associated pulmonary arterial hypertension: survival and prognostic factors
in the modern therapeutic era.
Degano B, Guillaume M, Savale L, et al

AIDS
. 2010 Jan 2;24(1):67-75.
Abstract

Treatment and Outcome of Pulmonary Arterial Hypertension in HIV-Infected
Patients: A Review of the Literature.
Cicalini S, Chinello P, Grilli E, Petrosillo N.
Curr HIV Res. 2009 Nov;7(6):589-96
Abstract


Pulmonary Arterial Hypertension in Human Immunodeficiency Virus Infection.
Talwar A, Sarkar P, Rosen MJ.
Postgrad Med. 2009 Sep;121(5):56-67
Abstract

HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern
therapeutic era.

Degano B, Guillaume M, Savale L, et al
 
AIDS
. 2009 Sep 16
Abstract

Pulmonary Arterial Hypertension and HIV Infection.
Degano B, Sitbon O, Simonneau G.

Semin Respir Crit Care Med
. 2009 Aug;30(4):440-7.
Abstract

HIV-associated pulmonary arterial hypertension: a clinical problem that is here to stay?
Murphy D, Girgis RE.
Int J Clin Pract. 2009 Mar;63
Abstract

Pulmonary arterial hypertension and its association with HIV infection: an overview
Lederman MM, Sereni D, Simonneau G, Voelkel NF.
 
AIDS.
2008 Sep;22 Suppl 3:S1-6.
Abstract

Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension.
Degano B, Yaďci A, Le Pavec J, Savale L, et al 

Eur Respir J.
2008 Sep 17.
Abstract
 
HIV-related pulmonary arterial hypertension: clinical presentation and management.
Sitbon O.
AIDS. 2008 Sep;22 Suppl 3:S55-62.
Abstract
 
Natural history of HIV-associated pulmonary arterial hypertension: trends in the HAART era.
Opravil M, Sereni D.

AIDS
. 2008 Sep;22 Suppl 3:S35-40.
Abstract
 
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension.
Degano B, Yaďci A, Le Pavec J, Savale L, et al 

Eur Respir J.
2008 Sep 17.
Abstract
 
Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic
anemias and HIV infection.
Barnett CF, Hsue PY, Machado RF.

JAMA.
2008 Jan 23;299(3):324-31.
Abstract

Bilateral Leg Swelling as the Initial and Predominant Presentation of HIV and Associated
Pulmonary Arterial Hypertension.

Cheung WY  
AIDS Patient Care STDS. 2007 May;21(5):293-6.
Abstract

HIV-associated pulmonary hypertension.
Ten Freyhaus H, Neumann T.
Dtsch Med Wochenschr. 2006 Dec;131 Suppl 9:S319-21
Abstract
 
Occult lymphadenopathic Kaposi's sarcoma associated with severe pulmonary hypertension:
A clinical hint about the potential role of HHV-8 in HIV-related pulmonary hypertension?
Gutierrez F, Masia M, Padilla S, et al
Clin Virol. 2006 Jul 31;
Abstract
 
Long-term survival and interruption of HAART in HIV-related pulmonary hypertension.
Zinkernagel AS, von Overbeck J, Opravil M, et al 
Eur J Clin Microbiol Infect Dis. 2005 Feb 12;
Abstract
 
Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term
epoprostenol therapy.
Myers SA, Ahearn GS, Angelica Selim M, Tapson VF.

J Am Acad Dermatol. 2004 Jul;51(1 Pt 1):98-102
Abstract
 
Inflammation in pulmonary arterial hypertension.
Dorfmuller P, Perros F, Balabanian K, Humbert M.
Eur Respir J. 2003 Aug;22(2):358-63.
Abstract

Treatment of HIV-Associated Pulmonary Hypertension with Treprostinil.
Cea-Calvo L, Escribano Subias P, Tello De Menesses R, et al.

Rev Esp Cardiol 2003 Apr;56(4):421-5
Abstract

FULL-TEXT ARTICLE
HIV-Related pulmonary hypertension: analytic review of 131 cases.
Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA.
Chest 2000 Oct;118(4):1133-41
Paper
 

 
          Conference Reports, Abstracts, and Posters
 
 
Highly active antiretroviral therapy (HAART) compared to HAART and Bosentan in
combination in naive patients with HIV-associated pulmonary hypertension
Barbarini G., Di Lorenzo G., Lucchini A., et al
(XVI International AIDS Conference)
Abstract
 
POSTER
Prevalence of Pulmonary Arterial Hypertension in HIV Positive Outpatients in the HAART Era
D Sereni, O Sitbon, C Lascoux-Combe,  et al

(13 CROI)
PDF Poster     Abstract

Increased Carotid Intima-media Thickness in HIV-infected Patients Is Associated with Increased
C-reactive Protein Levels and Increased Cytomegalovirus Specific T Cell Activation
P Hsue, P Hunt, D Waters. et al

(13 CROI)
Abstract


HIV Vascular Main Page Main New/Newsworthy  Home Page      

HIV-Related Vascular Disorders